(Q50750877)
Statements
Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia. (English)
1 reference
Abraham Weizman
1 reference
Rafael Stryjer
1 reference
Dana Ophir
1 reference
Faina Bar
1 reference
Baruch Spivak
1 reference
Rael D Strous
1 reference
1 July 2012
1 reference
35
1 reference
4
1 reference
161-164
1 reference